机译:综合性乳腺癌佐剂数字摘要
National Cancer Research Institute National Health Research Institutes Taipei Taiwan;
National Cancer Research Institute National Health Research Institutes Taipei Taiwan;
Radiology Department Veterans’ General Hospital and National Yang Ming University Taipei Taiwan;
Surgery Department Veterans’ General Hospital and National Yang Ming University Taipei Taiwan;
Pathology Department Veterans’ General Hospital and National Yang Ming University Taipei Taiwan;
Pathology Department Veterans’ General Hospital and National Yang Ming University Taipei Taiwan;
National Cancer Research Institute National Health Research Institutes Taipei Taiwan;
Cancer Center Veterans’ General Hospital and National Yang Ming University Taipei Taiwan;
Breast cancer; Adjuvanteoadjuvant therapy; Medical record; Visual evaluation summary sheet;
机译:早期乳腺癌最佳辅助化疗方案的选择以及HER2阳性乳腺癌的辅助靶向治疗:美国临床肿瘤学协会癌症适应指南安大略临床实践指南摘要
机译:南瑞典术前治疗海绵阳性乳腺癌。 2010-2017扫描 - B项目中新辅助治疗Her2-Postve乳腺癌的回顾性,综合调查
机译:批准摘要:来曲唑(Femara?片剂)用于绝经后乳腺癌的辅助和扩展辅助治疗:从加速批准转换为完全批准
机译:HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关:回顾性和多中心研究
机译:辅助化疗对乳腺癌患者脑功能的影响和癌症化学疗法的啮齿动物模型。
机译:综合性乳腺癌佐剂数字摘要
机译:综合性乳腺癌佐剂数字总结